CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cambridge BioMarketing, the world’s leading rare disease and specialty communications agency, today announced the public availability of Rare in Common, a film project honoring people living with the challenges of a rare disease.
The agency is making the documentary available to the public via its website one year after it was initially released, on Rare Disease Day 2016. Each year, Rare Disease Day calls attention to the public health issues associated with rare diseases, which affect approximately 350 million people worldwide, according to Global Genes.
Patients with rare diseases and their families share a common bond - their strength and courage. Rare in Common celebrates the lives of inspiring people in the rare community by giving them a forum to showcase their unique stories. The documentary follows several families and the day-to-day challenges they face living with a rare disease.
“Rare Disease Day is an important day of recognition for those living with rare conditions. The day serves as a natural milestone during which to share the amazing stories from patients around the world featured in Rare in Common,” said Maureen Franco, CEO, Cambridge BioMarketing. “By releasing the film publicly, we hope to not only continue to empower and unify people living with rare diseases, but to also educate the public about this common struggle faced by millions of Americans.”
In addition to the official public release of the documentary, Cambridge BioMarketing is celebrating Rare Disease Day with the #SupportTheSearch social media campaign to raise awareness for rare diseases and the need for research to find cures. As part of the campaign, which will run until March 6th, the agency has wrapped the inside and outside of a train car on the Massachusetts Bay Transportation Authority (MBTA) Red Line with facts about rare diseases and zebra stripe branding. The significance of zebra stripe design is that a “zebra” is medical slang for a rare diagnosis. Those who spot the train car are encouraged to share the image on social, and for every post, Cambridge BioMarketing will make a donation to Global Genes, NORD and the Rare Disease United Foundation to help to raise funds for rare disease research.
To view the documentary, please click here: rareincommon.com
About Cambridge BioMarketing
Cambridge BioMarketing is a rare disease and specialty communications agency, blending medical insights and award-winning creativity with deep experience to build some of the world’s most successful brands. With solutions for our clients that empower, educate, and activate, we bring physicians, specialists, and patient communities together to transform human health in the face of devastating, under-appreciated disease states. Founded in 2001, Cambridge BioMarketing has offices in Cambridge, MA and Oakland CA, and is a division of Everyday Health, Inc. For more information, visit: www.cambridgebmg.com.